Loading...

Home
ETF
CHRS

CHRS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CHRS News

Coherus Oncology Q1 2026 Earnings Call Insights

May 12 2026seekingalpha

CHRS Q1 2026 Earnings Transcript

May 11 2026NASDAQ.COM

Coherus Oncology to Release Q1 2026 Financial Results on May 11

May 04 2026Newsfilter

Coherus Oncology Reports Strong 2025 Financial Results

Mar 10 2026Yahoo Finance

Coherus Oncology Q4 2025 Earnings Call Highlights

Mar 10 2026seekingalpha

Coherus BioSciences Reports Q4 Earnings Miss

Mar 09 2026seekingalpha

Coherus BioSciences to Announce Q4 Earnings on March 9

Mar 08 2026seekingalpha

Coherus Oncology to Release 2025 Financial Results on March 9, 2026

Mar 02 2026Newsfilter

Coherus Oncology to Present at Upcoming Conferences

Feb 23 2026Newsfilter

Coherus Oncology Prices $50.1 Million Public Offering

Feb 13 2026NASDAQ.COM

Applied Materials Reports Strong Q1 Results, Shares Surge

Feb 13 2026Benzinga

Coherus Oncology Prices Public Offering at $1.75 per Share

Feb 13 2026seekingalpha

Coherus Oncology Prices Public Offering at $1.75 per Share

Feb 13 2026Newsfilter

Johnson & Johnson Partners with Coherus for Cancer Trial

Feb 04 2026seekingalpha

Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge

Jan 27 2026Newsfilter

Oncolytics Biotech Strengthens Leadership for Oncology Trials

Jan 27 2026PRnewswire